Sprint Bioscience AB (publ) (STO:SPRINT)

Sweden · Delayed Price · Currency is SEK

3.630

-0.120 (-3.20%)

Jul 24, 2026, 4:17 PM CET

Sprint Bioscience AB Financials Overview

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	153.37	167.65	67.44	54.32	0.45	35.07
Revenue Growth	141.25%	148.60%	24.15%	12051.01%	-98.72%	78.88%
Gross Profit	143.91	154.57	39.1	45.62	-12.48	24.64
Operating Income	87.99	97.29	-19.67	-0.85	-60.74	-25.63
Net Income	-15.8	91.74	-18.28	-0.44	-60.17	-25.08
Earnings Per Share	0.78	0.98	-0.26	-0.01	-1.43	-0.87
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Sweden	0.01	0.02	0.04	0.05	-
USA	167.16	65.63	50.45	0.04	35.11
Total	167.17	65.64	50.49	0.08	35.11

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	108.33	126.7	25.06	49.93	29.49	70.64
Total Debt	0	0	0	0	0	0
Net Cash (Debt)	108.33	126.7	25.06	49.93	29.49	70.64
Net Cash Growth	476.68%	405.68%	-49.82%	69.31%	-58.25%	160.92%
Net Cash Per Share	1.07	1.37	0.36	0.72	0.70	2.45

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	70.48	83.53	-23.36	22.87	-59.05	-40.12
Capital Expenditures	-0.07	-0.09	-1.3	-2.45	0	-2.71
Free Cash Flow	70.42	83.44	-24.65	20.42	-59.05	-42.82
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	93.84%	92.20%	57.98%	83.99%	-2792.62%	70.24%
Operating Margin	57.37%	58.03%	-29.17%	-1.56%	-13588.40%	-73.07%
Pretax Margin	-10.30%	54.72%	-27.10%	-0.81%	-13460.85%	-71.52%
Profit Margin	-10.30%	54.72%	-27.10%	-0.81%	-13460.90%	-71.52%
FCF Margin	45.91%	49.77%	-36.56%	37.59%	-13211.20%	-122.10%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	4.55	1.50	-	-	-	-
Forward PE	12.89	5.88	1.76	2.48	11.06	2.01
P/FCF Ratio	5.68	1.63	-	5.85	-	-
PS Ratio	2.58	0.81	1.62	2.20	84.91	5.36